Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?

Kethe Hermunen; Eila Lantto; Tuija Poussa; Caj Haglund; Pia Österlund

doi:10.1080/0284186X.2018.1431400

Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?

Kethe Hermunen, Eila Lantto, Tuija Poussa, Caj Haglund, Pia Österlund

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Acta Oncologica
Volym	57
Nummer	6
Sidor (från-till)	750-758
Antal sidor	9
ISSN	0284-186X
DOI	https://doi.org/10.1080/0284186X.2018.1431400
Status	Publicerad - 2018
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar
3126 Kirurgi, anestesiologi, intensivvård, radiologi

Åtkomst av dokument

10.1080/0284186X.2018.1431400

Citera det här

@article{0fb54fa666fb4200b8e5e6e40fd40ea8,

title = "Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?",

keywords = "TUMOR-MARKERS, COMBINATION CHEMOTHERAPY, RALTITREXED TOMUDEX(TM), TRANSIENT CEA, FOLINIC ACID, PHASE-I, THERAPY, SURGE, 5-FLUOROURACIL, GUIDELINES, 3122 Cancers, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Kethe Hermunen and Eila Lantto and Tuija Poussa and Caj Haglund and Pia {\"O}sterlund",

year = "2018",

doi = "10.1080/0284186X.2018.1431400",

language = "English",

volume = "57",

pages = "750--758",

journal = "Acta Oncologica",

issn = "0284-186X",